Q3 FY2026 · ended Aug 31, 2026 · Revenue $7.82M, -0.0% YoY · Filed Oct 9, 2026
Cryo-Cell International, Inc. (CCEL) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q3 of fiscal 2026, the quarter ended Aug 31, 2026, it reported revenue of $7.8 million and net income of $1.3 million. Free cash flow was $1.0 million. As of Aug 31, 2026 it held $4.2 million in cash and investments and $8.8 million in total debt.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- CCEL (NYSE)
- Fiscal year ends
- November 30
- Incorporated in
- DE
- Headquarters
- Oldsmar, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 862692
- Former names
- CRYO CELL INTERNATIONAL INC (until Oct 28, 2026)
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Viemed Healthcare, Inc. VMD
- Park Dental Partners, Inc. PARK
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Aug 31, 2026 |
Q2 FY2026 May 31, 2026 |
Q1 FY2026 Feb 28, 2026 |
Q4 FY2025 Nov 30, 2025 |
Q3 FY2025 Aug 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $7.8M | $7.8M | $7.7M | $7.8M | $7.8M |
| Operating income | $2.2M | $1.2M | $765,134 | -$4.0M | $1.9M |
| Net income | $1.3M | $554,586 | $47,108 | -$3.8M | $749,408 |
| Diluted EPS | $0.16 | $0.07 | $0.01 | -$0.48 | $0.09 |
| Operating cash flow | $1.1M | $1.8M | $651,827 | $1.3M | $2.5M |
| Free cash flow | $1.0M | $1.8M | $584,762 | $1.2M | $2.5M |
| Total assets | $62.3M | $60.7M | $60.9M | $61.7M | $63.2M |
| Total liabilities | $78.7M | $78.5M | $79.3M | $80.3M | $78.0M |
| Stockholders' equity | -$16.4M | -$17.8M | -$18.4M | -$18.6M | -$14.8M |
| Cash and investments | $4.2M | $3.2M | $2.9M | $3.3M | $3.2M |
| Total debt | $8.8M | $9.0M | $9.1M | $9.3M | $9.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Oct 28, 2026 | Oct 27, 2026 |
| ARS | Annual report to shareholders | Oct 13, 2026 | Nov 30, 2025 |
| 10-Q | Quarterly report | Oct 9, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 10, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | May 31, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
May 8, 2026 | May 6, 2026 |
All 908 Cryo-Cell International, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.